Petmed Express Inc
PETS· Nasdaq
Filed Jun 14, 2024 · 10-K · 75 days after period end · 0001040130-24-000046
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022 | Q4 2021 |
|---|---|---|---|---|
| Revenue | $65.05M | $59.79M | $65.85M | $71.68M |
| Net Income | -$5.02M | -$216.00K | $5.54M | $6.81M |
| EPS Diluted | — | — | $0.30 | $0.34 |
Petmed Express Inc · CIK 1040130 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Mar 31, 2024 · filed Jun 14, 2024 · 75 d after period end